Partner Headlines - GSK

  1. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative ...

    Benzinga
  2. New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In ...

    Benzinga
  3. Dodge & Cox 2014 Equity Year in Review

    GuruFocus
  4. Why Muscular Dystrophy Is Biotech's Favorite Orphan

    IBD
  5. Making Money With Charles Payne: 02/13/15

    FoxBusiness
  6. Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, ...

    Benzinga
  7. Stocks Edge Higher Friday; Glaxo, Taiwan Semi Muscle Up

    IBD
  8. Bestinfond's Top 5 New Buys During Q4

    GuruFocus
  9. Mylan Makes Deals In Women's Health, Lung Disease

    IBD
  10. Can GlaxoSmithKline Continue Striving in the Face of World Challenges? ...

    GuruFocus
  11. GlaxoSmithKline Expands Its Portfolio Of Medicines In The US ...

    Benzinga
  12. Benzinga's Weekend M&A Chatter

    Benzinga
  13. Gilead Sciences Still has More Upside

    GuruFocus
  14. Johnson & Johnson Riding High On Ebola Vaccines

    GuruFocus
  15. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  16. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD
  17. Isis Pharma To Develop GI Drugs With J&J

    IBD
  18. Pfizer, Home of Lipitor and Viagra, Lifts Dividend

    IBD
  19. Ebola Drug Work Continues

    IBD
  20. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD
  21. BioMarin CEO Sees Big Future For Prosensa Drug

    IBD
  22. Weekly 3-Year Low Highlights: RDS.B, GSK, WPZ, CLR

    GuruFocus
  23. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga
  24. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus
  25. Merck Bets $9.5 Billion On Cubist's War On Superbugs

    IBD
  26. GlaxoSmithKline's Move A Testament That Pharma Companies Are ...

    Benzinga
  27. The Top 5 European Stocks Held During Q3

    GuruFocus
  28. BioMarin buying Prosensa

    IBD
  29. BioMarin Buying Prosensa, Backing Up Troubled Drug

    IBD
  30. Screening Pharma Stocks Amid Turnaround

    YCharts
  31. Jeff Auxier Buys Berkshire Hathaway in Third Quarter

    GuruFocus
  32. Apollo may make Glaxo offer

    IBD
  33. Irving Kahn Starts New Position In GlaxoSmithKline

    GuruFocus
  34. Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014

    GuruFocus
  35. Insys Q3 Beats Estimates, Helping Stock Rebound

    IBD
  36. Kahn Brothers' Third Quarter Numbers

    GuruFocus
  37. Ebola Vaccine Contenders

    Benzinga
  38. Stock Futures Upshift On Data; Yahoo, Broadcom, Boeing Climb

    IBD
  39. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  40. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  41. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga
  42. Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear

    IBD
  43. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  44. Action Heats Up in Ebola-Related Equities

    FoxBusiness
  45. Guru Stocks at 52-Week Lows: BHP, GSK, UTX, SAP, TEF

    GuruFocus
  46. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  47. Royal Bank of Scotland

    IBD
  48. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD
  49. International Securities For A Diversified Income Portfolio

    GuruFocus
  50. Could European Funds Offer An Opportunity Now?

    Benzinga
  51. Widely Held Guru Stocks Trading In Europe

    GuruFocus
  52. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga
  53. Guru Stocks at 52-Week Lows: BHP, GSK, EC, VALE, ABB

    GuruFocus
  54. China Fines Glaxo For Bribes

    IBD
  55. Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF

    GuruFocus
  56. Stock Futures Down, But Not Far; Alibaba Sets IPO Price Range

    IBD
  57. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga
  58. GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) ...

    Benzinga
  59. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  60. 3 Dividend Kings From The U.K. I Love To Buy

    GuruFocus
  61. UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta ...

    Benzinga
  62. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus
  63. Intermune up on buyout buzz

    IBD
  64. You Should Consider Adding GlaxoSmithKline Based on Tremendous ...

    GuruFocus
  65. Drugmaker AstraZeneca Returns To Growth

    IBD
  66. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus
  67. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives ...

    Benzinga
  68. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga
  69. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus
  70. Glaxo, Genmab Report Positive Interim Result for Phase III Study ...

    Benzinga
  71. A Look at the Week's Top Dividend Growers

    GuruFocus
  72. Markets Little Changed Ahead Of The Federal Reserve's Policy ...

    Benzinga
  73. GlaxoSmithKline

    IBD
  74. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  75. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine ...

    Benzinga
  76. Morning Market Movers

    Benzinga
  77. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  78. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus
  79. British Stocks: Sweet Spot For European Value

    YCharts
  80. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  81. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart ...

    Benzinga
  82. Advances In HIV, Hep C Treatments Could Spark Renewed Interest ...

    Benzinga
  83. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  84. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies ...

    Benzinga
  85. Major British Companies Lead Top Guru-Held UK and Ireland Stocks ...

    GuruFocus
  86. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  87. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  88. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  89. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  90. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  91. Can Pfizer Make Up Its Loss?

    GuruFocus
  92. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  93. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  94. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  95. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing ...

    Benzinga
  96. Glaxo hurt by Advair scandal

    IBD
  97. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  98. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness
  99. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness
  100. China Rule Change Further Opens Yuan To World Markets

    IBD
Trading Center